<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the past 10 years numerous reports of cases referring to complications and their outcome with <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> type II (HIT II) have been published </plain></SENT>
<SENT sid="1" pm="."><plain>Clinically these symptoms are manifested as a combination of arterial and venous <z:hpo ids='HP_0001907'>thromboembolisms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Mostly affected are the vessels of the limbs, the abdomen, kidneys and coronary arteries </plain></SENT>
<SENT sid="3" pm="."><plain>We present the most rare initial manifestations of cerebral symptoms with <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0002018'>nausea</z:hpo>, change of character and <z:e sem="disease" ids="C0234533" disease_type="Disease or Syndrome" abbrv="">generalised convulsion</z:e>, which have found their origin in sinus vein <z:mp ids='MP_0005048'>thrombosis</z:mp> and the treatment with the heparinoid danaparoid </plain></SENT>
</text></document>